
Optimization model evaluates the benefits of selecting a portfolio of investigative sites based on advanced analytical models.
Optimization model evaluates the benefits of selecting a portfolio of investigative sites based on advanced analytical models.
Site selection is one of the most important and at the same time challenging problems in clinical trials planning. Poor site selection may cause enrollment delays, resource waste on low or zero enrollment, and even potentially compromise trial results.
Published: February 5th 2019 | Updated:
Published: March 1st 2019 | Updated: